Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-385-5 | CAS number: 106-32-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test item is not genotoxic in bacteria or in mammalian cells.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15.03.2016 - 08.04.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- - Salmonella typhimurium: histidine (his)
- Escherichia coli: tryptophan (trp) - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Mix
- Test concentrations with justification for top dose:
- Justification dose selection: Minor toxic effects were observed in the pre-experiment.
Experiment I: 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate
Experiment II: 33, 100, 333, 1000, 2500 and 5000 μg/plate for WP2 uvrA and 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate for all remaining strains - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative nontoxicity to the bacteria. - Untreated negative controls:
- yes
- Remarks:
- concurrent untreated
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine, 4-NOPD; 2-aminoanthracene, 2-AA
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar
DURATION
- Preincubation period: 60 minutes at 37 °C
- Exposure duration: 48 hours at 37 °C
DATA EVALUATION
- Counting: Petri Viewer Mk2 (Perceptive Instruments Ltd, Suffolk CB9 7BN, UK) with software program Ames Study Manager (v.1.21)
DETERMINATION OF CYTOTOXICITY
- Method: 8 concentrations were tested for toxicity and mutation induction with each 3 plates. Toxicity of the test item can be evident as a reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn. The pre-experiment is reported as main experiment I, since the following criteria are met: Evaluable plates (>0 colonies) at five concentrations or more in all strains used. Since minor toxic effects were observed 7 concentrations were tested and 5000 μg/plate was chosen as maximal concentration in Experiment II.
ACCEPTABILITY CRITERIA
- regular background growth in negative and solvent control
- spontaneous reversion rates in negative and solvent control are in the range of historical data
- positive control substances should produce an increase above the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control
- a minimum of 5 analysable dose levels should be present with at least 3 dose levels showing no signs of toxic effects, evident as a reduction in the number of revertants below the indication factor of 0.5. - Evaluation criteria:
- Test item is considered mutagen if biologically relevant increase in the number of revertants exceeds the threshold (twice or thrice) of the colony count of the corresponding solvent control. A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration. An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to OECD guideline 471, a statistical analysis of the data is not mandatory.
- Key result
- Species / strain:
- S. typhimurium, other: TA 1535 and TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1000 µg/plate without S9 in Experiment II
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate without S9 in Experiment I and at 100 - 5000 µg/plate without S9 and 2500 - 5000 µg/plate with S9 in Experiment II
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate with S9 in Experiment II
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In experiment II in the absence of S9 mix the induction factor was below the toxic border of 0.5 after treatment with the test item at a concentration of 1000 μg/plate. This effect was judged to be caused by statistical fluctuations of the rather low numbers of colonies in strain TA 1537 and does not represent a true toxic effect.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment at any concentration level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls. They showed a distinct increase in induced revertant colonies.
The historical range of positive controls was exceeded in strains TA 1535 and TA 98 (Exp. I) with metabolic activation. This effect indicates the sensitivity of the strains rather than compromising the assay. - Conclusions:
- Under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the Salmonella typhimurium and Escherichia coli strains used. Therefore, the test item is considered to be non-mutagenic.
- Executive summary:
In the current study the potential of the test item to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using Salmonella typhimurium strains TA1535, TA1537, TA98, TA 100, and Escherichia coli strain WP2uvrA was assessed. The study was perfomed according to OECD 471 and GLP.
The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate in Experiment I and at 33, 100, 333, 1000, 2500 and 5000 μg/plate in Experiment II for WP2 uvrA and at 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate in Experiment II for all remaining strains. No precipitation of the test item occurred up to the highest investigated dose.
The plates incubated with the test item showed reduced background growth in strains TA 1537, TA 98 and TA 100 in the second experiment without metabolic activation. Toxic effects, evident as a reduction in the number of revertants, were observed in strains TA 100 (from 100 to 5000 μg/plate without S9 mix and from 2500 to 5000 μg/plate with S9 mix), TA 1537 (at 1000 μg/plate without S9 mix) and WP2 uvrA (at 5000 μg/plate with S9 mix).
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test item at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
In conclusion, during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, the test item is considered to be non-mutagenic.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Read-across from ethyl hexanoate to ethyl octanoate is considered justified based on strong similarities with regard to chemical structure and metabolic pathways. A full read-across justification including comparison of toxicological profiles is included in section 13 of the IUCLID dossier.
- Reason / purpose for cross-reference:
- read-across source
- Test concentrations with justification for top dose:
- 45.0, 90.0, 180.0, 360.0, 720.0 and 1440.0 µg/mL
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Read-across was done from ethyl hexanoate. Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate did not induce gene mutations at the HPRT locus in V79 cells and therefore is considered to be non-mutagenic.
- Executive summary:
Read-across was done from ethyl hexanoate. In the current study the potential of ethyl hexanoate to induce gene mutations was assessed in an in vitro mammalian cell gene mutation test according to OECD 476 and GLP. The HPRT locus in the Chinese hamster cell line V79 was the target gene.
This in vitro test is an assay for the detection of forward gene mutations in mammalian cells. Gene mutations are discussed as an initial step in the carcinogenic process. The V79 cells are exposed to the test item both with and without exogenous metabolic activation. At a defined time interval after treatment the descendants of the treated original population are monitored for the loss of functional HPRT enzyme.
HPRT (hypoxanthine-guanine phosphoribosyl transferase) catalyzes the conversion of the nontoxic 6-TG (6-thioguanine) to its toxic ribophosphorylated derivative. Cells deficient in HPRT due to a forward mutation are resistant to 6-TG and are able to proliferate in the presence of 6-TG whereas the non-mutated cells die.
Phenotypic expression is achieved by allowing exponential growth of the cells for 7 - 9 days. The expression period is terminated by adding 6-TG to the culture medium.
The mutant frequency is determined by seeding known numbers of cells in medium containing the selective agent to detect mutant cells, and in medium without selective agent to determine the surviving cells. After a suitable period the colonies are counted. Mutant frequencies are calculated from the number of mutant colonies corrected for cell survival.
In order to establish a concentration response effect of the test item at least four concentration levels are tested. The highest concentration level should induce a reduced level of survival. To demonstrate the sensitivity of the test system reference mutagens are tested in parallel to the test item.
The assay was performed in two independent experiments. The treatment time was 4 hours in the first experiment with and without metabolic activation. The second experiment was performed with a treatment time of 24 hours without and 4 hours treatment with metabolic activation.
The maximum test item concentration (1440 μg/mL) was equal to a molar concentration of about 10 mM.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments.
The acceptability criteria were met. Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus showed the sensitivity of the test system and the activity of the metabolic activation system.
Under the current experimental conditions, ethyl hexanoate did not induce gene mutations at the HPRT locus in V79 cells and therefore is considered to be non-mutagenic.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate did not induce gene mutations at the HPRT locus in V79 cells and therefore is considered to be non-mutagenic.
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Read-across from ethyl hexanoate to ethyl octanoate is considered justified based on strong similarities with regard to chemical structure and metabolic pathways. A full read-across justification including comparison of toxicological profiles is included in section 13 of the IUCLID dossier.
- Reason / purpose for cross-reference:
- read-across source
- Test concentrations with justification for top dose:
- - Experiment I: 4 hours with and without S9 mix; 9.4, 16.4, 28.7, 50.2, 87.9, 154, 269, 471, 824 and 1442 µg/mL
- Experiment II: 20 hours without S9 mix; 127, 191, 286, 428, 642, 962, 1442 µg/mL - Species / strain:
- lymphocytes: Human lymphocytes from healthy non-smoking donors not receiving medication
- Remarks:
- Experiment I
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- lymphocytes: Human lymphocytes from healthy non-smoking donors not receiving medication
- Remarks:
- Experiment II
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- higher concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- Read-across was done from ethyl hexanoate. Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes and is considered to be non-mutagenic.
- Executive summary:
Read-across was done from ethyl hexanoate. In the current study the potential of ethyl hexanoate to induce micronuclei in human lymphocytes in vitro was assessed according to OECD 487 and in compliance to GLP.
The occurrence of micronuclei in interphase cells provides an indirect but easy and rapid measure of structural chromosomal damage and aneugenicity in cells that have undergone cell division during or after exposure to the test substance. Micronuclei arise from chromosomal fragments or whole chromosomes and are inducible by clastogens or agents affecting the spindle apparatus.
The induction of cytogenetic damage in human lymphocytes was assessed in two independent experiments and in each experimental group two parallel cultures were analyzed. Ethyl hexanoate was dissolved in DMSO. In Experiment I, the exposure period was 4 hours with and without S9 mix. In Experiment II, the exposure period was 20 hours without S9 mix.
The cells were stimulated for 48 hour with phytohemeagglutinine (PHA) to activate the proliferation, before exposure. After exposure, the cells were washed and left to recover for 16 hours before the cytokinesis was blocked by cytochalasin B for 20 minutes. The cells were prepared 40 hours after start of treatment with ethyl hexanoate.
The highest applied concentration in this study was 1442 µg/mL. Dose selection of the cytogenetic experiment was performed considering the molecular weight of ethyl hexanoate and the OECD Guideline 487. The chosen treatment concentrations are in Experiment I (4 hours with and without S9 mix): 9.4, 16.4, 28.7, 50.2, 87.9, 154, 269, 471, 824 and 1442 µg/mL and in Experiment II (20 hours without S9 mix): 127, 191, 286, 428, 642, 962, 1442 µg/mL.
In Experiment I, phase separation of ethyl hexanoate in culture medium was observed at 824 μg/mL and above in the absence and presence of S9 mix at the end of treatment. In addition, phase separation occurred in Experiment II in the absence of S9 mix at 962 μg/mL and above at the end of treatment.
No relevant influence on osmolarity or pH was observed.
In each experimental group two parallel cultures were analyzed. 1000 binucleate cells per culture were scored for cytogenetic damage on coded slides. To determine a cytotoxic effect the CBPI was determined in 500 cells per culture and cytotoxicity is described as % cytostasis.
In the absence and presence of S9 mix, no cytotoxicity was observed up to the highest evaluated concentration, which showed phase separation in Experiment I. In Experiment II, higher concentrations were not evaluable for cytogenetic damage due to strong cytotoxic effects.
In both experiments, in the absence and presence of S9 mix, no biologically relevant increase in the number of cells carrying micronuclei was observed.
In both experiments, either Demecolcin (100.0 ng/mL), MMC (1.5 μg/mL) or CPA (15.0 μg/mL) were used as positive controls and showed distinct increases in cells with micronuclei.
In conclusion, it can be stated that under the experimental conditions reported, ethyl hexanoate did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes. Therefore, ethyl hexanoate is considered to be non-mutagenic in this in vitro micronucleus test.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes. Therefore, the test item is considered to be non-mutagenic in this in vitro micronucleus test.
Referenceopen allclose all
Summary of individual results of Experiment I
Treatment |
Concentration (µg/plate) |
Revertant Colony counts (mean±SD) |
||||
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvr A |
||
Without metabolic activation |
||||||
DMSO |
n.a. |
15±5 |
8±2 |
32±8 |
158±25 |
43±10 |
Untreated |
n.a. |
17±2 |
8±2 |
31±12 |
164±14 |
51±1 |
Test item |
3 |
13±4 |
10±3 |
30±2 |
160 ± 7 |
40±10 |
10 |
8±1 |
7±1 |
24±3 |
162±9 |
30±7 |
|
33 |
14±2 |
8±3 |
27±4 |
148±32 |
38±3 |
|
100 |
9±3 |
13±1 |
23±4 |
109±4 |
42±6 |
|
333 |
9±4 |
11±1 |
29±1 |
92±7 |
44±1 |
|
1000 |
11±3 |
12±3 |
23±8 |
83±10 |
44±6 |
|
2500 |
8±2 |
11±4 |
23±5 |
83±20 |
40±6 |
|
5000 |
11±4 |
13±3 |
22±3 |
68±21 |
49±2 |
|
NaN3 |
10 |
1229 ± 17 |
|
|
2297 ± 65 |
|
4-NOPD |
10 |
|
|
387±66 |
|
|
4-NOPD |
50 |
|
89±6 |
|
|
|
MMS |
2.0 µL |
|
|
|
|
1028 ± 41 |
With metabolic activation |
||||||
DMSO |
n.a. |
15±3 |
12±6 |
24±5 |
137±18 |
47±7 |
Untreated |
n.a. |
12±3 |
14±5 |
37±10 |
161 ± 9 |
54±9 |
Test item |
3 |
14±2 |
10±2 |
44±10 |
127±10 |
52±4 |
10 |
11±1 |
10±2 |
33±4 |
119 ± 7 |
57±8 |
|
33 |
9±2 |
12±3 |
37±7 |
112 ± 7 |
50±8 |
|
100 |
17±0 |
15±6 |
34±6 |
112±11 |
53±11 |
|
333 |
18±6 |
16±3 |
34±6 |
143 ± 7 |
45±3 |
|
1000 |
14±2 |
14±4 |
40±14 |
163±13 |
48±7 |
|
2500 |
14±1 |
11±4 |
32±4 |
131±14 |
44±7 |
|
5000 |
12±3 |
10±0 |
30 ± 3 |
148 ± 23 |
37 ± 12 |
|
2-AA |
2.5 |
554±67 |
120 ± 21 |
5323 ± 212 |
3057 ± 382 |
|
2-AA |
10 |
|
|
|
|
440 ± 22 |
NaN3 = sodium azide; 2-AA = 2-aminoanthracene; 4-NOPD = 4-nitro-o-phenylene-diamine; MMS = methyl methane sulfonate
Summary of individual results of Experiment II
Treatment |
Concentration (µg/plate) |
Revertant Colony counts (mean±SD) |
||||
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvr A |
||
Without metabolic activation |
||||||
DMSO |
n.a. |
11±3 |
10±3 |
19±3 |
167±8 |
45±3 |
Untreated |
n.a. |
11±5 |
9±4 |
24±4 |
178±20 |
46±3
|
Test item |
3 |
12±2 |
10±3 |
19±2 |
169±16 |
|
10 |
13±3 |
10±4 |
24±5 |
142±16 |
|
|
33 |
9±1 |
9±1 |
22±7 |
118±8 |
51±4
|
|
100 |
10±0 |
10±4 |
23±5 |
69±12 |
39±4 |
|
333 |
10±2 |
8±2 |
16 ± 5 |
61 ± 5R |
33±14 |
|
1000 |
10±2 |
4 ± 0M R |
17 ± 10R |
46±10R |
40±6 |
|
2500 |
10±3 |
5 ± 1M R |
17 ± 4R |
65±21R |
41±4 |
|
5000 |
9±4 |
5 ± 1M R |
9 ± 1M R |
43 ± 1R |
38 ± 8 |
|
NaN3 |
10 |
1194 ± 11 |
|
|
1996 ± 123 |
|
4-NOPD |
10 |
|
|
397 ± 30 |
|
|
4-NOPD |
50 |
|
102±4 |
|
|
|
MMS |
2.0 µL |
|
|
|
|
764±22 |
With metabolic activation |
||||||
DMSO |
n.a. |
12±2 |
11±4 |
33±4 |
131±9 |
49±9 |
Untreated |
n.a. |
12±2 |
10±2 |
37±2 |
200±7 |
51±1 |
Test item |
3 |
13±4 |
8±1 |
36±8 |
123±5 |
|
10 |
10±2 |
8±2 |
28±2 |
126±14 |
|
|
33 |
12±2 |
9±3 |
33±7 |
124±12 |
54±8 |
|
100 |
11±2 |
13±3 |
40±1 |
134±10 |
52±7 |
|
333 |
11±2 |
9±3 |
33±6 |
137±10 |
49±8 |
|
1000 |
11±1 |
7±5 |
35±6 |
116±11 |
49±10 |
|
2500 |
8±2 |
8±3 |
25±3 |
57±9 |
35±4 |
|
5000 |
12±3 |
11 ± 2 |
26 ± 2 |
57 ± 9 |
16 ± 2 |
|
2-AA |
2.5 |
401±33 |
89 ± 15 |
4498 ± 698 |
3034 ± 203 |
|
2-AA |
10 |
|
|
|
|
523 ± 38 |
M = manual count
R = reduced background growth
NaN3 = sodium azide; 2-AA = 2-aminoanthracene; 4-NOPD = 4-nitro-o-phenylene-diamine; MMS = methyl methane sulfonate
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
For this endpoint there are multiple studies available assessing the genotoxicity of ehtyl octanoate and the read-across substance ethyl hexanoate.
Regarding the genotoxicity in bacteria there are 2 Ames tests available for the substance itself.
For ethyl octanoate there is a recent Ames test (2016) and an older study (1984). The first study was according to OECD 471 and used the Salmonella typhimurium strains TA1535, TA1537, TA98, TA 100, and Escherichia coli strain WP2uvrA with and without liver microsomal activation. The test concentrations were 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate for the Salmonella typhimurium strains and 33, 100, 333, 1000, 2500 and 5000 μg/plate for the Escherichia coli strain. No precipitation of the test item occurred and no substantial increase in revertant colony numbers of any of the tester strains was observed following treatment with ethyl octanoate at any dose level with or without metabolic activation (S9 mix).
In the older study (1984) no OECD guideline was followed, however, the study was according to the method of Ames, McCann & Yamasaki (1975), the test strains S. typhimurium TA92, TA1535, TA100, TA1537, TA94 and TA98 were included, and the genotoxicity was investigated with and without metabolic activation. Ethyl octanoate was found to be negative for all S. typhimurium strains, confirming the first study.
Based on the results, ethyl octanoate is not mutagenic in Salmonella typhimurium and Escherichia coli strains.
Regarding the genotoxicity in mammalian cells, read-across is done to ethyl hexanoate. For ethyl hexanoate a recent OECD 476 (in vitro mammalian cell gene mutation test) and recent OECD 487 (in vitro mammalian cell micronucleus test) are available.
To investigate the potential of ethyl hexanoate to induce gene mutations in vitro in mammalian cell, a gene mutation test according to OECD 476 was performed. Chinese hamster V79 cells were exposed to ethyl hexanate with and without metabolic activation. The HPRT locus is the target gene and the loss of functional HPRT enzyme is monitored with the use of 6-TG (6-thioguanine) as cells deficient in HPRT are resistant to 6-TG and are able to proliferate in the presence of 6-TG whereas the non-mutated cells die. The mutant frequency is calculated from the number of mutant colonies corrected for cell survival.
Treatment time was 4 hours in the first experiment with and without metabolic activation and 24 hours in the second experiment without and 4 hours treatment with metabolic activation.
The maximum test item concentration (1440 μg/mL) was equal to a molar concentration of about 10 mM.
No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments, while the acceptability criteria were met.
Therefore, ethyl hexanoate did not induce gene mutations at the HPRT locus in V79 cells and therefore is considered to be non-mutagenic.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate did not induce gene mutations at the HPRT locus in V79 cells and therefore is considered to be non-mutagenic.
The potential of ethyl hexanoate to induce chromosomal aberrations in vitro was assessed according to OECD 487 in human lymphocytes. In Experiment I, the exposure period was 4 hours with and without S9 mix and in Experiment II, the exposure period was 20 hours without S9 mix.
The test concentrations were in Experiment I: 9.4, 16.4, 28.7, 50.2, 87.9, 154, 269, 471, 824 and 1442 µg/mL and in Experiment II: 127, 191, 286, 428, 642, 962, 1442 µg/mL.
1000 binucleate cells per culture were scored for cytogenetic damage on coded slides, the CBPI was determined in 500 cells per culture.
In both experiments no biologically relevant increase in the number of cells carrying micronuclei was observed, while the controls were valid. Ethyl hexanoate did not induce micronuclei in human lymphocytes.
Based on the result, and on the structural, chemical and toxicological similarities between ethyl hexanoate and ethyl octanoate, ethyl octanoate is considered to be unable to induce chromosome breaks and/or gain or loss in this test system and should be considered non-mutagenic.
An older study (1984) on ethyl octanoate confirms this latter observation. In that study (1984) study, similar to the OECD Guideline 473, Chinese hamster fibroblast cells were exposed to ethyl octanoate at different doses for 24 and 48 hours (maximum dose tested was 2.0 mg/mL), without metabolic activation. Chromosome analysis was done by observing 100 well-spread metaphases under the microscope. The incidence of polyploid cells as well as of cells with structural chromosomal aberrations such as chromatid or chromosome gaps, breaks, exchanges, ring formations, fragmentations and others, were recorded. Ethyl octanoate was found to be negative and no structural aberrations were observed after 48 hours.
Taking togehter all the information above, ethyl octanoate is not genotoxic in bacteria or mammalian cells.
Justification for classification or non-classification
In the Regulation No 1274/2008 on classification, labelling and packaging, the criteria for mutagenicity are set in section 3.5. The data from the in vitro mutagenicity chromosome aberration tests, in vitro mammalian cell gene mutation test and bacterial reverse mutation tests indicate that the test item is not to be considered as genotoxic/mutagenic according to the Regulation EC No 1272/2008, as all results were negative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.